Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Zafrani

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Histopathology|December 21, 2000
High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 casesB Zafrani, M H Aubriot, E Mouret, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissuesP Touraine, J F Martini, B Zafrani, et al.
International Journal of Cancer|March 12, 1998
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancerS Rozan, A Vincent-Salomon, B Zafrani, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapyA Vincent-Salomon, M Carton, P Freneaux, et al.
Annales De Pathologie|January 1, 1996
[Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]A L Balaton, J M Coindre, F Collin, et al.
Virchows Archiv : an International Journal of Pathology|March 10, 1999
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
Der Pathologe|January 1, 1997
[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community]J P Sloane, I Amendoeira, N Apostolikas, et al.
Human Pathology|October 22, 1998
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening PathologyC W Elston, J P Sloane, I Amendoeira, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Histopathology|December 21, 2000
High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 casesB Zafrani, M H Aubriot, E Mouret, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissuesP Touraine, J F Martini, B Zafrani, et al.
International Journal of Cancer|March 12, 1998
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancerS Rozan, A Vincent-Salomon, B Zafrani, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapyA Vincent-Salomon, M Carton, P Freneaux, et al.
Annales De Pathologie|January 1, 1996
[Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]A L Balaton, J M Coindre, F Collin, et al.
Virchows Archiv : an International Journal of Pathology|March 10, 1999
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
Der Pathologe|January 1, 1997
[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community]J P Sloane, I Amendoeira, N Apostolikas, et al.
Human Pathology|October 22, 1998
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening PathologyC W Elston, J P Sloane, I Amendoeira, et al.
Pageof 8